For over 20 years, VOI Consulting has performed due diligence and provided pharmaceutical companies, venture capitalists, and private equity firms with sophisticated quantitative models to support investment decisions in the life-sciences.
Building on the extensive body of empirical pharmaceutical-industry economic research, VOI combines knowledge of market dynamics with situation-specific analysis to produce probability-based forecasts that help clients understand risks, sensitivities, and outcomes.